Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Cush

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Rheumatic Diseases Clinics of North America|November 10, 2012
Malignancy risks with biologic therapiesJohn J Cush, Kathryn H Dao
Rheumatic Diseases Clinics of North America|November 10, 2012
Nonserious infections: should there be cause for serious concerns?Kathryn H Dao, Morley Herbert, Nadia Habal, et al.
The Journal of Rheumatology|December 17, 2009
Can tumor necrosis factor inhibitors be safely used in pregnancy?Yaser M Ali, Bindee Kuriya, Catalina Orozco, et al.
The Journal of Rheumatology|November 17, 2017
Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid ArthritisJeffrey R Curtis, Lang Chen, Maria I Danila, et al.
The Journal of Rheumatology|April 3, 2019
Perceptions of Pregnancy and Lactation from the Pregnancy and Lactation Autoimmune Network RegistryBrooke S Mills, Kathryn H Dao, Kristen M Tecson, et al.
The Journal of Rheumatology|November 3, 2015
Pregnancy Outcomes in Subjects Exposed to Certolizumab PegolMegan E B Clowse, Douglas C Wolf, Frauke Förger, et al.
Arthritis Care & Research|July 12, 2012
Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trialsElizabeth C Hsia, John J Cush, Eric L Matteson, et al.
Seminars in Arthritis and Rheumatism|May 24, 2012
Proceedings of the 2012 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, George Martin, John J Cush, et al.
The Journal of Rheumatology. Supplement|February 6, 2009
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidenceStanley B Cohen, Marc D Cohen, John J Cush, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2018
Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety DatabaseMegan E B Clowse, Angela E Scheuerle, Christina Chambers, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Rheumatic Diseases Clinics of North America|November 10, 2012
Malignancy risks with biologic therapiesJohn J Cush, Kathryn H Dao
Rheumatic Diseases Clinics of North America|November 10, 2012
Nonserious infections: should there be cause for serious concerns?Kathryn H Dao, Morley Herbert, Nadia Habal, et al.
The Journal of Rheumatology|December 17, 2009
Can tumor necrosis factor inhibitors be safely used in pregnancy?Yaser M Ali, Bindee Kuriya, Catalina Orozco, et al.
The Journal of Rheumatology|November 17, 2017
Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid ArthritisJeffrey R Curtis, Lang Chen, Maria I Danila, et al.
The Journal of Rheumatology|April 3, 2019
Perceptions of Pregnancy and Lactation from the Pregnancy and Lactation Autoimmune Network RegistryBrooke S Mills, Kathryn H Dao, Kristen M Tecson, et al.
The Journal of Rheumatology|November 3, 2015
Pregnancy Outcomes in Subjects Exposed to Certolizumab PegolMegan E B Clowse, Douglas C Wolf, Frauke Förger, et al.
Arthritis Care & Research|July 12, 2012
Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trialsElizabeth C Hsia, John J Cush, Eric L Matteson, et al.
Seminars in Arthritis and Rheumatism|May 24, 2012
Proceedings of the 2012 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, George Martin, John J Cush, et al.
The Journal of Rheumatology. Supplement|February 6, 2009
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidenceStanley B Cohen, Marc D Cohen, John J Cush, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2018
Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety DatabaseMegan E B Clowse, Angela E Scheuerle, Christina Chambers, et al.
Pageof 3